drugset / Trial / NCT01601327

Effects of Medications in Patients With Hypogonadism

NCT01601327

Phase 4 Completed 119 enrolled Gulhane School of Medicine
RandomizedCrossoverOpen-labelTreatment

Summary

The aim of the present study was to demonstrate the influences of three different treatment strategies on biochemical parameters and testicular volume (TV) in patients with idiopathic hypogonadotropic hypogonadism (IHH).

Timeline

Start
2008-01
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 50 mg
Subject Testosterone Enanthate Small molecule 250 mg
Subject human chorionic gonadotropin Protein / enzyme biologic 5000 iu